Ophthalmologic Manifestations of Escherichia Coli Clinical Presentation

  • Author: Donny W Suh, MD, FAAP; Chief Editor: Hampton Roy Sr, MD   more...
 
Updated: Mar 9, 2012
 

History

Past ocular history should be assessed, as follows:

  • Previous eye injury
  • Infection
  • Surgery
  • Diabetic eye disease

Past medical history should be assessed, as follows:

  • Diabetes
  • Immunocompromised host
  • Intravenous drug abuser
  • Urinary tract infection

Visual complaints should be assessed, as follows:

  • Decreased vision
  • Eyelid edema
  • Diplopia red eye
  • Mild-to-severe ocular pain
  • Photophobia
  • Discharge
Next

Physical

Signs are as follows:

  • Focal white opacity in the corneal stroma
  • Epithelial defect that stains fluorescent
  • Stroll edema and inflammation surrounding the infiltrate
  • Conjunctival injection
  • Corneal thinning
  • Anterior chamber reaction
  • Hypopyon (as is shown in the image below)Bacterial corneal ulcer with hypopyon. Bacterial corneal ulcer with hypopyon.
  • Mucopurulent discharge
  • Upper eyelid edema
  • Posterior synechiae
  • Hyphema
  • Glaucoma
Previous
Next

Causes

Exogenous causes are as follows:

  • Immunocompromised state
  • Irregular corneal epithelium
  • Trauma
  • Ocular surgery

Endogenous causes are as follows:

  • Urinary tract infection
  • Endocarditis
  • Meningitis
  • Systemic infection
Previous
Proceed to Differential Diagnoses
 
 
Contributor Information and Disclosures
Author

Donny W Suh, MD, FAAP  Clinical Assistant Professor, Pediatric Ophthalmology Service, University of Nebraska Medical Center; Pediatric Ophthalmologist, Adult Strabismus Specialist, Wolfe Eye Clinic, PC; Consulting Staff, Blank Children's Hospital, Mercy Medical Center of Des Moines, Iowa Methodist Hospital of Des Moines, and Marshalltown Medical Center

Donny W Suh, MD, FAAP is a member of the following medical societies: American Academy of Ophthalmology, American Academy of Pediatrics, and American Medical Association

Disclosure: Alcon Honoraria Speaking and teaching

Specialty Editor Board

Kilbourn Gordon III, MD, FACEP  Urgent Care Physician

Kilbourn Gordon III, MD, FACEP is a member of the following medical societies: American Academy of Ophthalmology and Wilderness Medical Society

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

J James Rowsey, MD  Former Director of Corneal Services, St Luke's Cataract and Laser Institute

J James Rowsey, MD is a member of the following medical societies: American Academy of Ophthalmology, American Association for the Advancement of Science, American Medical Association, Association for Research in Vision and Ophthalmology, Florida Medical Association, Pan-American Association of Ophthalmology, Sigma Xi, and Southern Medical Association

Disclosure: Nothing to disclose.

Lance L Brown, OD, MD  Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri

Disclosure: Nothing to disclose.

Chief Editor

Hampton Roy Sr, MD  Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences

Hampton Roy Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, and Pan-American Association of Ophthalmology

Disclosure: Nothing to disclose.

References

  1. Chen CJ, Starr CE. Epidemiology of gram-negative conjunctivitis in neonatal intensive care unit patients. Am J Ophthalmol. Jun 2008;145(6):966-970. [Medline].

  2. Raju B, Bali T, Thiagarajan G, Rao V, Das T, Sharma S. Physicochemical properties and antibacterial activity of the precipitate of vancomycin and ceftazidime: implications in the management of endophthalmitis. Retina. Feb 2008;28(2):320-5. [Medline].

  3. Amini E, Ghasemi M, Daneshjou K. A five-year study in Iran of ophthalmia neonatorum: prevalence and etiology. Med Sci Monit. Feb 2008;14(2):CR90-96. [Medline].

  4. Aronson SB, Elliott JH. Ocular Inflammation. St. Louis, MO: CV Mosby; 1972:103-5, 112-4.

  5. Balestrazzi A, Blasi MA, Primitivo S, Balestrazzi E. Escherichia coli endophthalmitis after trans-scleral resection of uveal melanoma. Eur J Ophthalmol. Sep-Oct 2002;12(5):437-9. [Medline].

  6. Bonadio WA, Smith DS, Madagame E, et al. Escherichia coli bacteremia in children. A review of 91 cases in 10 years. Am J Dis Child. Jun 1991;145(6):671-4. [Medline].

  7. Charoo NA, Kohli K, Ali A, Anwer A. Ophthalmic delivery of ciprofloxacin hydrochloride from different polymer formulations: in vitro and in vivo studies. Drug Dev Ind Pharm. Feb 2003;29(2):215-21. [Medline].

  8. Cordido M, Fernandez-Vigo J, Cordido F, Rey AD. Bilateral metastatic endophthalmitis in diabetics. Acta Ophthalmol (Copenh). Apr 1991;69(2):266-7. [Medline].

  9. Eisenstein BI. Escherichia coli infections. In: Harrison's Principles of Internal Medicine. 1994:661-3.

  10. Epstein SP, Bottone EJ, Asbell PA. Susceptibility testing of clinical isolates of pseudomonas aeruginosa to levofloxacin, moxifloxacin, and gatifloxacin as a guide to treating pseudomonas ocular infections. Eye Contact Lens. Sep 2006;32(5):240-4. [Medline].

  11. Fanning WL, Stubbert J, Irwin ES, Aronson MD. A case of bilateral Escherichia coli endogenous endophthalmitis. Am J Med. Aug 1976;61(2):295-7. [Medline].

  12. Faraawi R, Fong IW. Escherichia coli emphysematous endophthalmitis and pyelonephritis. Case report and review of the literature. Am J Med. Mar 1988;84(3 Pt 2):636-9. [Medline].

  13. Glasser DB, Baum J. Antibacterial agents. In: Infections of the Eye. 1996:207-30.

  14. Hyndiuk RA, Cokington CD. Bacterial keratitis. In: Infections of the Eye. 1996:323-47.

  15. Katz HR. A retrospective study of endophthalmitis rates comparing quinolone antibiotics. Am J Ophthalmol. Oct 2005;140(4):771-2; author reply 772-3. [Medline].

  16. Ko KS, Lee MY, Song JH, et al. Prevalence and characterization of extended-spectrum beta-lactamase-producing Enterobacteriaceae isolated in Korean hospitals. Diagn Microbiol Infect Dis. Aug 2008;61(4):453-9. [Medline].

  17. Munoz Morente A, Baron Ramos MA, Mateos Fernandez S, Reguera Iglesias JM. Endogenous bacterial endophthalmitis: a case report and brief review [in Spanish]. An Med Interna. Dec 2004;21(12):597-8. [Medline].

  18. Park SB, Searl SS, Aquavella JV, Erdey RA. Endogenous endophthalmitis caused by Escherichia coli. Ann Ophthalmol. Mar 1993;25(3):95-9. [Medline].

  19. Regnier A, Schneider M, Concordet D, Toutain PL. Intraocular pharmacokinetics of intravenously administered marbofloxacin in rabbits with experimentally induced acute endophthalmitis. Am J Vet Res. Mar 2008;69(3):410-5. [Medline].

  20. Sanford JP, Gilbert DN, Sande MA. Antimicrobial. In: Guide to Antimicrobial Therapy. 1997:47.

  21. Sekimoto M, Hayasaka S, Setogawa T, Shigeno K. Endogenous Escherichia coli endophthalmitis in a patient with autosomal-dominant polycystic kidney disease. Ann Ophthalmol. Dec 1991;23(12):458-9. [Medline].

  22. Shammas HF. Endogenous E. coli endophthalmitis. Surv Ophthalmol. Mar-Apr 1977;21(5):429-35. [Medline].

  23. Sim DA, Feasey N, Wren S, Breathnach A, Thompson G. Cross-infection risk of felt-tipped marker pens in cataract surgery. Eye. Jul 11 2008;[Medline].

  24. Starr MB. A retrospective study of endophthalmitis rates comparing quinolone antibiotics. Am J Ophthalmol. Oct 2005;140(4):769-70; author reply 770-1. [Medline].

  25. Sunakawa K, Nonoyama M, Ooishi T, et al. The trend of childhood bacterial meningitis in Japan (2000-2002) [in Japanese]. Kansenshogaku Zasshi. Oct 2004;78(10):879-90. [Medline].

  26. Tseng CY, Liu PY, Shi ZY, et al. Endogenous endophthalmitis due to Escherichia coli: case report and review. Clin Infect Dis. Jun 1996;22(6):1107-8. [Medline].

  27. Turck M, Schaberg D. Infections due to enterobacteriaceae. In: Harrison's Principles of Internal Medicine. 1980:629-34.

  28. Walmsley RS, David DB, Allan RN, Kirkby GR. Bilateral endogenous Escherichia coli endophthalmitis: a devastating complication in an insulin-dependent diabetic. Postgrad Med J. Jun 1996;72(848):361-3. [Medline].

  29. Wann SR, Liu YC, Yen MY, et al. Endogenous Escherichia coli endophthalmitis. J Formos Med Assoc. Jan 1996;95(1):56-60. [Medline].

  30. Zhang YQ, Wang WJ. Treatment outcomes after pars plana vitrectomy for endogenous endophthalmitis. Retina. Sep 2005;25(6):746-50. [Medline].

 
Previous
Next
 
Bacterial corneal ulcer with hypopyon.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.